| Trisha Lynn Thoma, MD | |
|
250 S Crescent Dr, Mason City, IA 50401-2926 | |
| (641) 494-5380 | |
| (641) 494-5381 |
| Full Name | Trisha Lynn Thoma |
|---|---|
| Gender | Female |
| Speciality | Otolaryngology |
| Experience | 12 Years |
| Location | 250 S Crescent Dr, Mason City, Iowa |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1770849317 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207YX0007X | Otolaryngology - Plastic Surgery Within The Head & Neck | MD44577 (Iowa) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mercyone North Iowa Medical Center | Mason city, IA | Hospital |
| Iowa Specialty Hospital - Belmond | Belmond, IA | Hospital |
| Franklin General Hospital | Hampton, IA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mason City Clinic Pc | 2860385572 | 34 |
| North Iowa Mercy Clinics | 7810809076 | 242 |
| Mason City Clinic Pc | 2860385572 | 34 |
| North Iowa Mercy Clinics | 7810809076 | 242 |
News Archive
A Kansas State University-led team is researching ways to stop the spread of norovirus, a contagious stomach illness that infects one in 15 Americans each year, according to the Centers for Disease Control and Prevention.
Pathway Genomics Corporation, a San Diego-based CLIA and CAP accredited clinical laboratory that offers genetic testing services worldwide, today announced the launch of Hereditary Colorectal Cancer DNA Insight, the company's premier hereditary cancer genetic test. Based on a simple saliva sample, the test uses next-generation sequencing (NGS) technology to identify gene alterations or mutations that increase a patient's risk of developing certain types of cancer.
InNexus Biotechnology Inc. (TSX.V: IXS) (www.ixsbio.com), a drug development company commercializing the next generation of antibodies based on its groundbreaking Dynamic Cross Linking (DXL™) technology, today announced the development of a new psoriasis product based on its proprietary dermal permeating Transmab™ technology.
According to the Centers for Disease Control and Prevention (CDC), the number of whooping cough cases in the United States could reach a 50-year high in 2012. The CDC's forecast is based on the fact that, as of July 2012, twice as many cases of whooping cough - or pertussis as it's referred to clinically - had been reported to the CDC thus far this year as compared to the same point in 2011.
New research indicates that obesity in the general population may be genetically linked to how our bodies digest carbohydrates.
› Verified 9 days ago
| Entity Name | North Iowa Mercy Clinics |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780278242 PECOS PAC ID: 7810809076 Enrollment ID: O20031105000273 |
News Archive
A Kansas State University-led team is researching ways to stop the spread of norovirus, a contagious stomach illness that infects one in 15 Americans each year, according to the Centers for Disease Control and Prevention.
Pathway Genomics Corporation, a San Diego-based CLIA and CAP accredited clinical laboratory that offers genetic testing services worldwide, today announced the launch of Hereditary Colorectal Cancer DNA Insight, the company's premier hereditary cancer genetic test. Based on a simple saliva sample, the test uses next-generation sequencing (NGS) technology to identify gene alterations or mutations that increase a patient's risk of developing certain types of cancer.
InNexus Biotechnology Inc. (TSX.V: IXS) (www.ixsbio.com), a drug development company commercializing the next generation of antibodies based on its groundbreaking Dynamic Cross Linking (DXL™) technology, today announced the development of a new psoriasis product based on its proprietary dermal permeating Transmab™ technology.
According to the Centers for Disease Control and Prevention (CDC), the number of whooping cough cases in the United States could reach a 50-year high in 2012. The CDC's forecast is based on the fact that, as of July 2012, twice as many cases of whooping cough - or pertussis as it's referred to clinically - had been reported to the CDC thus far this year as compared to the same point in 2011.
New research indicates that obesity in the general population may be genetically linked to how our bodies digest carbohydrates.
› Verified 9 days ago
| Entity Name | Iowa Specialty Hospital- Clarion |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396760153 PECOS PAC ID: 3375451347 Enrollment ID: O20031120000622 |
News Archive
A Kansas State University-led team is researching ways to stop the spread of norovirus, a contagious stomach illness that infects one in 15 Americans each year, according to the Centers for Disease Control and Prevention.
Pathway Genomics Corporation, a San Diego-based CLIA and CAP accredited clinical laboratory that offers genetic testing services worldwide, today announced the launch of Hereditary Colorectal Cancer DNA Insight, the company's premier hereditary cancer genetic test. Based on a simple saliva sample, the test uses next-generation sequencing (NGS) technology to identify gene alterations or mutations that increase a patient's risk of developing certain types of cancer.
InNexus Biotechnology Inc. (TSX.V: IXS) (www.ixsbio.com), a drug development company commercializing the next generation of antibodies based on its groundbreaking Dynamic Cross Linking (DXL™) technology, today announced the development of a new psoriasis product based on its proprietary dermal permeating Transmab™ technology.
According to the Centers for Disease Control and Prevention (CDC), the number of whooping cough cases in the United States could reach a 50-year high in 2012. The CDC's forecast is based on the fact that, as of July 2012, twice as many cases of whooping cough - or pertussis as it's referred to clinically - had been reported to the CDC thus far this year as compared to the same point in 2011.
New research indicates that obesity in the general population may be genetically linked to how our bodies digest carbohydrates.
› Verified 9 days ago
| Entity Name | Mason City Clinic Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043254055 PECOS PAC ID: 2860385572 Enrollment ID: O20040205001159 |
News Archive
A Kansas State University-led team is researching ways to stop the spread of norovirus, a contagious stomach illness that infects one in 15 Americans each year, according to the Centers for Disease Control and Prevention.
Pathway Genomics Corporation, a San Diego-based CLIA and CAP accredited clinical laboratory that offers genetic testing services worldwide, today announced the launch of Hereditary Colorectal Cancer DNA Insight, the company's premier hereditary cancer genetic test. Based on a simple saliva sample, the test uses next-generation sequencing (NGS) technology to identify gene alterations or mutations that increase a patient's risk of developing certain types of cancer.
InNexus Biotechnology Inc. (TSX.V: IXS) (www.ixsbio.com), a drug development company commercializing the next generation of antibodies based on its groundbreaking Dynamic Cross Linking (DXL™) technology, today announced the development of a new psoriasis product based on its proprietary dermal permeating Transmab™ technology.
According to the Centers for Disease Control and Prevention (CDC), the number of whooping cough cases in the United States could reach a 50-year high in 2012. The CDC's forecast is based on the fact that, as of July 2012, twice as many cases of whooping cough - or pertussis as it's referred to clinically - had been reported to the CDC thus far this year as compared to the same point in 2011.
New research indicates that obesity in the general population may be genetically linked to how our bodies digest carbohydrates.
› Verified 9 days ago
| Entity Name | Belmond Community Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821122623 PECOS PAC ID: 1052201852 Enrollment ID: O20040316001360 |
News Archive
A Kansas State University-led team is researching ways to stop the spread of norovirus, a contagious stomach illness that infects one in 15 Americans each year, according to the Centers for Disease Control and Prevention.
Pathway Genomics Corporation, a San Diego-based CLIA and CAP accredited clinical laboratory that offers genetic testing services worldwide, today announced the launch of Hereditary Colorectal Cancer DNA Insight, the company's premier hereditary cancer genetic test. Based on a simple saliva sample, the test uses next-generation sequencing (NGS) technology to identify gene alterations or mutations that increase a patient's risk of developing certain types of cancer.
InNexus Biotechnology Inc. (TSX.V: IXS) (www.ixsbio.com), a drug development company commercializing the next generation of antibodies based on its groundbreaking Dynamic Cross Linking (DXL™) technology, today announced the development of a new psoriasis product based on its proprietary dermal permeating Transmab™ technology.
According to the Centers for Disease Control and Prevention (CDC), the number of whooping cough cases in the United States could reach a 50-year high in 2012. The CDC's forecast is based on the fact that, as of July 2012, twice as many cases of whooping cough - or pertussis as it's referred to clinically - had been reported to the CDC thus far this year as compared to the same point in 2011.
New research indicates that obesity in the general population may be genetically linked to how our bodies digest carbohydrates.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Trisha Lynn Thoma, MD 250 S Crescent Dr, Mason City, IA 50401-2926 Ph: (641) 494-5400 | Trisha Lynn Thoma, MD 250 S Crescent Dr, Mason City, IA 50401-2926 Ph: (641) 494-5380 |
News Archive
A Kansas State University-led team is researching ways to stop the spread of norovirus, a contagious stomach illness that infects one in 15 Americans each year, according to the Centers for Disease Control and Prevention.
Pathway Genomics Corporation, a San Diego-based CLIA and CAP accredited clinical laboratory that offers genetic testing services worldwide, today announced the launch of Hereditary Colorectal Cancer DNA Insight, the company's premier hereditary cancer genetic test. Based on a simple saliva sample, the test uses next-generation sequencing (NGS) technology to identify gene alterations or mutations that increase a patient's risk of developing certain types of cancer.
InNexus Biotechnology Inc. (TSX.V: IXS) (www.ixsbio.com), a drug development company commercializing the next generation of antibodies based on its groundbreaking Dynamic Cross Linking (DXL™) technology, today announced the development of a new psoriasis product based on its proprietary dermal permeating Transmab™ technology.
According to the Centers for Disease Control and Prevention (CDC), the number of whooping cough cases in the United States could reach a 50-year high in 2012. The CDC's forecast is based on the fact that, as of July 2012, twice as many cases of whooping cough - or pertussis as it's referred to clinically - had been reported to the CDC thus far this year as compared to the same point in 2011.
New research indicates that obesity in the general population may be genetically linked to how our bodies digest carbohydrates.
› Verified 9 days ago
Phillip C Lee, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 250 S Crescent Dr, Mason City, IA 50401 Phone: 641-494-5380 Fax: 641-494-5381 | |
Dr. Timothy Dettmer, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 250 S Crescent Dr, Mason City, IA 50401 Phone: 641-494-5380 Fax: 641-494-5381 | |
Dr. Vishram Jalukar, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 250 S Crescent Dr, Mason City, IA 50401 Phone: 641-494-5380 Fax: 641-494-5381 | |
Dr. Daniel Lee, M.D. Otolaryngology Medicare: May Accept Medicare Assignments Practice Location: 250 S Crescent Dr, Mason City, IA 50401 Phone: 641-494-5380 Fax: 641-494-5381 | |
Dr. Henry Richard Diggelmann, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 250 S Crescent Dr, Mason City, IA 50401 Phone: 641-494-5380 Fax: 641-494-5381 |